Infinity Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Infinity Pharmaceuticals

04/05/2022 24:53

* Infinity Pharmaceuticals Inc  INFI.OQ  reported a
quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
March. The mean expectation of eight analysts for the quarter
was for a loss of 13 cents per share.
    * Revenue rose 39.6% to $652.00 thousand from a year ago; 
analysts expected $345.17 thousand. 
    * Infinity Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 14 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Infinity Pharmaceuticals Inc shares had fallen by 31.1%
this
quarter and lost 65.1% so far this year.
    * The company reported a quarterly loss of $12.44 million.
    * Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 3 at 11:53 p.m.  ​All
figures in US dollars unless otherwise stated